Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
2011
n/a
LTM Revenue $178M
LTM EBITDA $39.1M
$406M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Synektik has a last 12-month revenue of $178M and a last 12-month EBITDA of $39.1M.
In the most recent fiscal year, Synektik achieved revenue of $160M and an EBITDA of $31.3M.
Synektik expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Synektik valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $115M | $160M | XXX | XXX | XXX |
Gross Profit | $12.5M | $33.9M | XXX | XXX | XXX |
Gross Margin | 11% | 21% | XXX | XXX | XXX |
EBITDA | $21.1M | $31.3M | XXX | XXX | XXX |
EBITDA Margin | 18% | 20% | XXX | XXX | XXX |
Net Profit | $2.6M | $13.5M | XXX | XXX | XXX |
Net Margin | 2% | 8% | XXX | XXX | XXX |
Net Debt | $3.1M | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Synektik's stock price is PLN 205 (or $53).
Synektik has current market cap of PLN 1.7B (or $449M), and EV of PLN 1.6B (or $406M).
See Synektik trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$406M | $449M | XXX | XXX | XXX | XXX | $3.46 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Synektik has market cap of $449M and EV of $406M.
Synektik's trades at 2.3x LTM EV/Revenue multiple, and 10.4x LTM EBITDA.
Analysts estimate Synektik's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Synektik and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $406M | XXX | XXX | XXX |
EV/Revenue | 2.4x | XXX | XXX | XXX |
EV/EBITDA | 11.8x | XXX | XXX | XXX |
P/E | 19.4x | XXX | XXX | XXX |
P/E/Growth | 0.9x | XXX | XXX | XXX |
EV/FCF | 34.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSynektik's NTM/LTM revenue growth is 15%
Synektik's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Synektik's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Synektik's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Synektik and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 40% | XXX | XXX | XXX | XXX |
EBITDA Margin | 20% | XXX | XXX | XXX | XXX |
EBITDA Growth | 48% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 35% | XXX | XXX | XXX | XXX |
Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
Opex to Revenue | 13% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Synektik acquired XXX companies to date.
Last acquisition by Synektik was XXXXXXXX, XXXXX XXXXX XXXXXX . Synektik acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Synektik founded? | Synektik was founded in 2011. |
Where is Synektik headquartered? | Synektik is headquartered in Poland. |
Is Synektik publicy listed? | Yes, Synektik is a public company listed on WAR. |
What is the stock symbol of Synektik? | Synektik trades under SNT ticker. |
When did Synektik go public? | Synektik went public in 2011. |
Who are competitors of Synektik? | Similar companies to Synektik include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Synektik? | Synektik's current market cap is $449M |
What is the current revenue of Synektik? | Synektik's last 12-month revenue is $178M. |
What is the current EBITDA of Synektik? | Synektik's last 12-month EBITDA is $39.1M. |
What is the current EV/Revenue multiple of Synektik? | Current revenue multiple of Synektik is 2.3x. |
What is the current EV/EBITDA multiple of Synektik? | Current EBITDA multiple of Synektik is 10.4x. |
What is the current revenue growth of Synektik? | Synektik revenue growth between 2023 and 2024 was 40%. |
Is Synektik profitable? | Yes, Synektik is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.